These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 12555491

  • 1. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Mar; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 5. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ, Jaguste V, Nanivadekar AS.
    J Assoc Physicians India; 1998 May; Suppl 1():41-51. PubMed ID: 11233386
    [Abstract] [Full Text] [Related]

  • 6. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R, Derosa G, Zoppi A, Rinaldi A, Preti P, Lazzari P, Mugellini A.
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [Abstract] [Full Text] [Related]

  • 7. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Jan; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 8. [Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].
    Rodríguez Pérez JC, Novoa Novoa J, Caballero A, Anabitarte A, Plaza C, Palop L, Rodríguez Esparragón F.
    Nefrologia; 2005 Jan; 25(5):500-8. PubMed ID: 16392299
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R, Varadharajan S, Kathale A, Nagraj LM, Periyandavar I, Nayak UP, Sharma A, Bolmall C, Baliga VP.
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [Abstract] [Full Text] [Related]

  • 10. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Jul; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 11. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL, Hanson C, Lucas C, Rosenblatt S, Rosenstock J, Whittier F, Wistran D, Riche C, Mulcahy WS.
    Clin Ther; 1993 Oct; 15(1):79-87. PubMed ID: 8458057
    [Abstract] [Full Text] [Related]

  • 13. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR, Yeolekar ME, Tripathi KK, Giri J, Maity AK, Chopda M, Gujarathi S, Maroli S, Maity A, LORD Trial.
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [Abstract] [Full Text] [Related]

  • 15. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP, Whitehead EM, Crawford V, McVeigh GE, Johnston GD.
    Q J Med; 1991 Nov; 81(295):919-28. PubMed ID: 1808632
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P, Sitagliptin Study 019 Group.
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [Abstract] [Full Text] [Related]

  • 17. [Anti-hypertensive efficacy and tolerability of sustained-release prazosin hydrochloride. A Brazilian multicenter study].
    Spritzer N.
    Arq Bras Cardiol; 1990 Oct; 55(4):263-6. PubMed ID: 2078143
    [Abstract] [Full Text] [Related]

  • 18. Nicardipine retard in the therapy of elderly diabetic hypertensives: final report of observational study.
    Antonicelli R, Pagelli P, Paciaroni E.
    J Hypertens Suppl; 1992 Apr; 10(2):S69-72. PubMed ID: 1593306
    [Abstract] [Full Text] [Related]

  • 19. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 20. Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.
    Pasanisi F, Imperatore G, Vaccaro O, Iovine C, Ferrara LA.
    Nutr Metab Cardiovasc Dis; 1999 Apr; 9(2):73-7. PubMed ID: 10726112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.